Biodexa Pharmaceuticals plc - American Depositary Shares (NQ:BDRX)

0.4501 -0.0299 (-6.23%)

Delayed Quote Updated: 11:26 AM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biodexa Pharmaceuticals plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

S&P 500 Gains 1%; Exxon Mobil Posts Downbeat Earnings ↗

April 26, 2024

Via Benzinga

Topics Stocks

US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 Points ↗

April 26, 2024

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 29, 2024

Via Benzinga

Biodexa's MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers

March 28, 2024

Via ACCESSWIRE

Biodexa Takes Aim At Type 1 Diabetes With Innovative Drug Candidate Tolimidone

March 01, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 28, 2024

Via Benzinga

Crude Oil Surges Over 2%; MSC Industrial Shares Fall After Q2 Results ↗

March 28, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 15 points on Thursday. The Dow traded up 0.06% to 39,785.29 while the NASDAQ fell 0.13% to 16,383.85. The...

Via Benzinga

Topics Stocks

Extend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows Potential ↗

March 28, 2024

Biodexa Pharmaceuticals' MTX110, revolutionizing brain cancer treatment with innovative drug delivery technology. Early trials show promising survival rate extensions in Diffuse Midline Glioma and...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 28, 2024

Via Benzinga

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 28, 2024

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of...

Via Benzinga

Gold Gains 1%; Walgreens Narrows Earnings Forecast ↗

March 28, 2024

U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday. The Dow traded up 0.06% to 39,785.87 while the NASDAQ rose 0.06% to 16,408.04. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today? ↗

March 28, 2024

Biodexa Pharmaceuticals stock is up alongside heavy trading of BDRX after announcing positive news from a brain cancer treatment trial.

Via InvestorPlace

US Stocks Flat; Initial Jobless Claims Fall To 210,000 ↗

March 28, 2024

U.S. stocks traded mixed this morning, with the Dow Jones index trading almost flat on Thursday. Following the market opening Thursday, the Dow traded down 0.02% to 39,753.17 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 18, 2024

Via Benzinga

What's Going On With Rare/Orphan Disease Focused-Biodexa Pharmaceuticals Stock Friday? ↗

February 23, 2024

Biodexa Pharmaceuticals shares R&D update, revealing Phase 1 trial results for MTX110 in diffuse midline glioma patients. Study shows promising median overall survival of 16.5 months.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 14, 2024

Via Benzinga

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 13, 2024

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Via Benzinga

Why Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today? ↗

February 13, 2024

Biodexa Pharmaceuticals surges 30.3% in premarket on Tuesday. Discover the latest SEC filing, cancer research updates, and patent news.

Via Benzinga

Topics Intellectual Property Regulatory Compliance

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 13, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 13, 2024

Pre-market stock movers are a hot topic on Tuesday and we're diving into all of the biggest winners and losers this morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

January 31, 2024

Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest ones worth keeping an eye on this morning!

Via InvestorPlace

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge ↗

December 19, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The...

Via Benzinga

Topics Stocks

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 19, 2023

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy...

Via Benzinga

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results ↗

December 19, 2023

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 19, 2023

Via Benzinga

Why Biodexa Pharmaceuticals (BDRX) Shares Are Getting Hammered ↗

December 19, 2023

Biodexa Pharmaceuticals PLC-ADR (NASDAQ: BDRX) shares are trading lower by 31.7% to $2.07 Tuesday morning after the company disclosed the pricing of a public offering.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 13, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.